Topic:Epidemiology
Epidemiology in horses involves the study of the distribution and determinants of health-related states and events in equine populations. It encompasses the investigation of patterns, causes, and effects of diseases and health conditions within horse populations. This field of study aims to identify risk factors for disease and targets for preventive healthcare. Key components of equine epidemiology include disease surveillance, outbreak investigation, and the study of disease dynamics within herds or regions. Research in this area often focuses on infectious diseases, zoonotic diseases, and the impact of environmental factors on equine health. This page compiles peer-reviewed research studies and scholarly articles that explore various aspects of epidemiology in horses, including disease prevalence, transmission pathways, and strategies for disease prevention and control.
Survey of histoplasmin skin test reactions among horses in Mexico. In a 3-month period, 2,221 Mexican horses were skin tested for sensitivity to Histoplasma capsulatum antigen. The prevalence of reactivity was 7.9%. There was little evidence of a difference in geographic distribution of sensitivity. The prevalence of reactivity increased with age of the horse. This increment with age is thought to be a function of time exposure to the organism and possibly of selective survival of the horses.
Preparation and evaluation of inactivated Venezuelan equine encephalitis vaccines. No abstract available
Observations on the free-living stages of strongylid nematodes of the horse. Observations have been made on the development and survival of the free-living stages in faeces deposited out of doors at different times of year, and on the migration of infective larvae to the surrounding herbage. Laboratory experiments were performed to assist in the interpretation of the field observations. Studies were made on the rate of development to the infective stage in faeces kept at different temperatures. The rates at which eggs and larvae of Strongylus vulgaris, S edentatus, S. equinus and Trichonema nassatum developed on faecal-agar cultures at different temperatures were compa...
Equine abortion (herpes) virus: strain differences in susceptibility to inactivation by dithiothreitol. The infectivity of equine abortion (herpes) virus (EAV) was inactivated by treatment with reduced dithiothreitol (DTT). According to their susceptibility to DTT, the EAV strains could be divided into three groups. The vaccine strain RAC-H (419) proved to be more resistant to DTT than all of the other 14 strains tested. The hemagglutinin of EAV was also inactivated by DTT; no strain differences were observed in this respect.
Stability of live attenuated Venezuelan equine encephalitis vaccine. Reconstituted Venezulean equine encephalitis vaccine was found to retain significant titers of plaque-forming virus after storage at 4 or 22 C for 24 hr.
The radiographic status of the left fore fetlock of winning thoroughbreds at Ontario racetracks in 1970. FOR MANY YEARS, concern has been expressed at the wastage of young Thoroughbreds at the racetrack. This concern even manifested itself in the publication of a book (1) which referred to the prevailing practice of prematurely start-ing the racing career of the Thoroughbred long before it had attained sufficient maturity to engage in stiff, damaging competition. This is not a fault of the Thoroughbred industry alone, because in certain parts of the U.S.A., Quarter Horses less than two years of age are already racing. We could swing to the opposite extreme, of course, to the pleasure horse world ...
Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The highest level of viremia measured was 7 x 10(3) to 8 x 10(3) plaqueforming units per ml. No adverse reactions to the vaccine were observed in any horses, including 42 pregnant mares and their resulting foals.